Carver Bancorp, Inc. Appoints Three New Board Members:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Carver Bancorp, Inc. Appoints Three New Board Members: Lewis Jones III, Kenneth Knuckles and Colvin Grannum

NEW YORK, Sept. 27, 2013 (GLOBE NEWSWIRE) -- Carver Bancorp, Inc. ("Carver" or the "Company") (Nasdaq: CARV ), the holding company for Carver Federal Savings Bank, announced that Lewis Jones III, Managing Principal and Co-Founder of 5 Stone Green Capital; Kenneth Knuckles, President and Chief Executive Officer of the Upper Manhattan Empowerment Zone Development Corporation (UMEZ); and Colvin Grannum, President of the Bedford Stuyvesant Restoration Corporation, have been appointed to the Company's Board of Directors, effective October 1, 2013.

"Carver is pleased to announce the appointment of three exceptional business leaders to the Board as we work to ensure that Carver remains a strong and trusted resource in the urban communities that we serve," said Robert Holland, Lead Independent Director of Carver. "Their collective experience will be of tremendous value to our Board and management team as we work in concert to guide the Company on the execution of its business strategy going forward."

Deborah C. Wright, Carver Chairman and Chief Executive Officer added, "As we accelerate our efforts to complete Carver's turnaround and increase our revenue growth, we are very fortunate to add to our Board three individuals with on-the-ground operational and financial experience, as well as key business relationships in our marketplace."

The appointments bring the total number of Directors at Carver Bancorp, Inc. and Carver Federal Savings Bank to ten. 

Lewis Jones III is Managing Principal and Co-Founder at 5 Stone Green Capital, an asset management firm that seeks capital appreciation and current income from investments in energy efficient and sustainably designed green real estate developments, which have positive social and environmental impacts. Mr. Jones has more than 27 years of distinguished real estate industry and investment experience. Previously, Mr. Jones was an executive for over 22 years at JPMorgan Chase. He was Co-Portfolio Manager of the JPMorgan Urban Renaissance Property Fund and a senior member of the Acquisitions Team at JPMorgan Asset Management. Previously, Mr. Jones served as President of the Chase Community Development Corporation where he held overall management responsibility for the firm's community development lending and investment activities, which totaled more than $5 billion during his 17-year tenure. Mr. Jones holds his J.D. and M.B.A. from Columbia University and his A.B. from Harvard University. He serves on the boards of Mt. Sinai Hospital Center and the Housing Partnership Development Corporation.

Kenneth Knuckles is President and Chief Executive Officer of the Upper Manhattan Empowerment Zone Development Corporation (UMEZ), a position he has held since January 2003. Since 1996, UMEZ has invested more than $230 million in the economy of Upper Manhattan, including $140 million under Mr. Knuckles' leadership, leveraged nearly $1 billion in private capital, and created nearly 9,000 jobs. Mr. Knuckles is also Vice Chair of the New York City Planning Commission, twice appointed by Mayor Michael R. Bloomberg. Before joining UMEZ, Mr. Knuckles was Vice President of Support Services and Chief Procurement Officer at Columbia University, where he was responsible for providing administrative and support services to the faculty and administration, including acquisition of more than $250 million in goods and services annually. From 1990 through 1993, he was Commissioner of the New York City Department of General Services during the David N. Dinkins mayoral administration. From 1987 through 1990, Mr. Knuckles served as Deputy Borough President of Bronx County. Mr. Knuckles holds a B.S. in Architecture from the University of Michigan and a J.D. from the Howard University School of Law. He is a Board Trustee of Continuum Health Group and NYC Big Brothers and Big Sisters. Mr. Knuckles was recently appointed by Governor Andrew M. Cuomo to be a member of the New York City Regional Economic Development Council.

Colvin W. Grannum is President and Chief Executive Officer of Bedford Stuyvesant Restoration Corporation ("Restoration"), the nation's first community development corporation. Over the past 46 years, Restoration has been the catalyst for the investment of over $500 million in Central Brooklyn. Through its facilities and programs, Restoration currently serves approximately 50,000 people annually. During Mr. Grannum's tenure, Restoration has participated in transactions resulting in the preservation and development of more than 1,000 units of affordable housing. Restoration's commercial revitalization activities have resulted in more than $10 million of private sector investment in new businesses and $24 million of public sector investment in local commercial infrastructure and cultural facilities. Prior to joining Restoration in 2001, Mr. Grannum served as Chief Executive Officer of Bridge Street Development Corporation, a leading church affiliated community development corporation. Before his career in community development, Mr. Grannum practiced law for over 17 years in the public and private sectors.  He is chairperson of the board of Bedford Stuyvesant Early Childhood Development Center, Inc.  He also serves as a director of the New York City Housing Development Corporation, Local Initiatives Support Corporation, New York City Workforce Investment Board, and the Center for New York City Neighborhoods.  Mr. Grannum holds a B.A. from the University of Pennsylvania and a J.D. from Georgetown University Law Center.

About Carver Bancorp, Inc.

Carver Bancorp, Inc. is the holding company for Carver Federal Savings Bank, a federally chartered stock savings bank. Carver Federal Savings Bank, the largest African- and Caribbean-American run bank in the United States operates nine full-service branches in the New York City boroughs of Brooklyn, Queens and Manhattan. For further information, please visit the Company's website at www.carverbank.com .

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, risks and uncertainties. More information about these factors, risks and uncertainties is contained in our filings with the Securities and Exchange Commission.

Ruth Pachman/Michael Herley Kekst and Company 212-521-4800

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding ADHD and the Role of RELEXXII in Treatment

Updated Category News Views 215

Supporting ADHD Awareness: The Role of RELEXXII This month marks a significant time for acknowledging and educating people about Attention Deficit Hyperactivity Disorder (ADHD). Alora Pharmaceuticals, the leading manufacturer behind RELEXXII® (methylphenidate hydrochloride extended-release tablet), is deeply committed to this cause. ADHD impacts various dimensions of...

Continue Reading
New Class Action Filed Against Paragon 28 Over Alleged Fraud

Updated Category News Views 111

Introduction to the New Class Action Against Paragon 28 Hagens Berman has recently taken action by filing a class action lawsuit against Paragon 28, Inc. (NYSE: FNA) alongside several of its senior executives. The case aims to hold the company accountable for alleged fraudulent activities affecting investors. Overview of the Allegations The lawsuit extends an ongoing...

Continue Reading
Subway Teams Up with ARC Raiders for Gaming Promo

Updated Category News Views 16

What’s Cooking Between Subway and Embark Studios? Subway’s diving headfirst into the gaming world, folks. It’s not a piece of cake to see a sandwich giant team up with a game studio, but today, Subway’s sidestepping the typical food deal. Instead, it's sharpening its digital claws with Embark Studios, a Stockholm-based game developer. They’re gearing up for the...

Continue Reading
CagriSema Breakthrough: Weight Loss Success in Adults

Updated Category News Views 312

Significant Weight Loss Achieved with CagriSema in Clinical Trial In recent findings, Novo Nordisk has unveiled compelling results from the extensive REDEFINE 1 trial, focusing on the innovative weight loss treatment, CagriSema. This clinical study assessed the efficacy of subcutaneous CagriSema—a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg—in...

Continue Reading
Endor Labs Achieves Remarkable Growth in Application Security

Updated Category News Views 390

Endor Labs Shows Impressive Revenue Growth Endor Labs, a leader in application security, proudly announces a significant milestone: a whopping 225% year-over-year revenue growth. This achievement highlights the increasing demand for robust security measures that can keep pace with the rapid transformations in software development, especially given the rise of AI...

Continue Reading